v3.26.1
Discontinued Operations - Schedule of Disposal Groups (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Operating expenses          
Loss on assets held for sale       $ 15,965 $ 31,848
Loss from discontinued operations, net of tax $ (3,777)   $ (27,871) (14,019) (31,790)
B Medical Systems Business | Discontinued Operations, Held-for-Sale          
Revenue          
Total revenue 22,793   17,206 35,896 34,797
Cost of revenue          
Total cost of revenue 14,988   11,533 26,956 26,261
Gross profit 7,805   5,673 8,940 8,536
Operating expenses          
Research and development 1,122   1,201 2,723 2,836
Selling, general and administrative 5,534   7,729 8,903 13,916
Loss on assets held for sale 6,269 $ 9,700 31,848 15,965 31,848
Restructuring charges 183   364 299 678
Total operating expenses 13,108   41,142 27,890 49,278
Operating loss (5,303)   (35,469) (18,950) (40,742)
Interest income (expense), net 0   (15) 1 (10)
Other income (expense), net 749   (604) 1,166 (74)
Loss before income taxes (4,554)   (36,088) (17,783) (40,826)
Income tax benefit (917)   (8,597) (4,301) (9,416)
Loss from discontinued operations, net of tax (3,637)   (27,491) (13,482) (31,410)
B Medical Systems Business | Discontinued Operations, Held-for-Sale | Products          
Revenue          
Total revenue 19,266   15,886 30,280 30,119
Cost of revenue          
Total cost of revenue 11,948   10,462 21,266 20,368
B Medical Systems Business | Discontinued Operations, Held-for-Sale | Services          
Revenue          
Total revenue 3,527   1,320 5,616 4,678
Cost of revenue          
Total cost of revenue $ 3,040   $ 1,071 $ 5,690 $ 5,893